Nutritional supplement to treat macular degeneration

  • US 6,660,297 B2
  • Filed: 03/23/2001
  • Issued: 12/09/2003
  • Est. Priority Date: 03/23/2001
  • Status: Expired due to Term
First Claim
Patent Images

1. A composition comprising on a daily dosage basis:

  • approximately 7 to 10 times the RDA of vitamin C;

    approximately 13 to 18 times the RDA of vitamin E;

    approximately 6 to 10 times the RDA of vitamin A in the form of beta-carotene;

    approximately 4 to 7 times the RDA of zinc; and

    at least 1.6 mg copper.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×